Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide add-on study for interictal epileptiform discharges in children with epilepsy
IRCT20120821010634N5Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in epilepsy, sponsored by Hamadan University of Medical Sciences. Primary endpoints: Change in interictal epileptiform discharges on EEG, Number of epileptic waves per minute and 1 more. Started Nov 2024; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT20120821010634N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120821010634N5.